文献速递神经肿瘤

脑侵犯作为非典型脑膜瘤分级的独立标准是否充分?

Is brain invasion sufficient as a stand-alone criterion for grading atypical meningioma?
PubMed 文献 · J Neurosurg · 2023-03-31

研究纳入1006例按最新WHO标准病理诊断为良性或非典型脑膜瘤的患者,比较伴脑侵犯的良性脑膜瘤、经典非典型脑膜瘤及无脑侵犯良性脑膜瘤的预后。结果显示伴脑侵犯良性脑膜瘤预后居中,脑侵犯是全人群及非典型脑膜瘤亚组复发的独立危险因素,提示现行分级对脑侵犯的诊断效应重视不足。

要点

  • 1006例中282例(28.0%)病理确认存在脑侵犯。
  • 伴脑侵犯良性脑膜瘤与经典非典型脑膜瘤无复发生存差异显著(p<0.001)。
  • 多变量Cox分析示脑侵犯与全人群复发风险独立相关(HR 1.46,95%CI 1.01-2.12,p=0.049)。

核心结论

  • 伴脑侵犯的良性脑膜瘤预后通常居中,可与良性脑膜瘤及经典非典型脑膜瘤区分,提示非典型脑膜瘤分级对脑侵犯诊断效应的重视不足。
  • 作者认为增加对非典型脑膜瘤患者脑侵犯的重视可能有助于术后决策和个体化治疗改进。

研究设计与样本

  • 研究纳入1006例按最新WHO分类标准病理诊断为良性或非典型脑膜瘤的患者。
  • 将非典型脑膜瘤病例进一步分为伴脑侵犯良性脑膜瘤和经典非典型脑膜瘤,收集临床、病理和随访资料。
  • 采用Kaplan-Meier曲线并以log-rank检验比较,行单变量和多变量分析。

主要发现

  • 全部1006例良性或非典型脑膜瘤患者中282例(28.0%)病理确认存在脑侵犯。
  • 伴脑侵犯良性脑膜瘤与经典非典型脑膜瘤的无复发生存差异显著(p<0.001)。
  • 伴脑侵犯良性脑膜瘤与无脑侵犯良性脑膜瘤的无复发生存差异显著(p=0.003)。
  • 多变量Cox分析示脑侵犯与全人群复发风险升高独立相关(HR 1.46,95%CI 1.01-2.12,p=0.049)。
  • 非典型脑膜瘤亚组中脑侵犯与复发风险升高独立相关(HR 2.21,95%CI 1.32-3.71,p=0.003);伴与不伴脑侵犯良性脑膜瘤亚组中HR 1.89,95%CI 1.01-3.56,p=0.049。

临床怎么用

  • 作者认为增加对非典型脑膜瘤患者脑侵犯的重视可能有助于术后决策和个体化治疗改进。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite the controversy surrounding brain invasion (BI) as the sole indicator used to diagnose atypical meningioma, this criterion was still incorporated in the 2021 WHO classification scheme. In this study, the authors investigated the reproducibility of this prognostic effect and the impact of BI on the prognosis in otherwise benign meningioma (benign meningioma with BI). METHODS: Patients (n = 1006) with a pathological diagnosis of benign or atypical meningioma according to the latest WHO classification criteria were enrolled in this study. In patients with atypical meningioma, the cases were further categorized as benign meningioma with BI and classical atypical meningioma. Clinical, pathological, and follow-up data were collected. Kaplan-Meier curves were compared with a log-rank test, and univariate and multivariate analyses were performed. RESULTS: The study patient cohort included 282 (28.0%) individuals who were pathologically confirmed as having BI among all 1006 patients with benign or atypical meningioma. A significant difference in recurrence-free survival was observed between patients who had benign meningioma with BI and those who had classical atypical meningioma (p < 0.001), as well as between patients with benign meningiomas and those without BI (p = 0.003). Multivariate Cox analysis indicated that BI was independently associated with increased risk of relapse in the entire population (HR 1.46, 95% CI 1.01-2.12, p = 0.049) and in the atypical meningioma subcohort (HR 2.21, 95% CI 1.32-3.71, p = 0.003), as well as the benign meningioma with and without BI subcohorts (HR 1.89, 95% CI 1.01-3.56, p = 0.049). Moreover, patients with classical atypical meningiomas had a risk of relapse four times higher than those who had benign meningioma with BI (p < 0.001). CONCLUSIONS: The findings demonstrate that benign meningioma with BI typically has an intermediate prognosis and can be differentiated from benign meningioma and classical atypical meningioma, which suggests that the importance of the diagnostic effect of BI is insufficiently accounted for in grading of atypical meningioma. Increased emphasis on the presence of BI in patients with atypical meningioma may be helpful in postsurgical decision-making and facilitating improvements in individual therapy.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Li HY, Ying YZ, Zheng D, et al. Is brain invasion sufficient as a stand-alone criterion for grading atypical meningioma? J Neurosurg. 2023. PMID: 37561905. doi:10.3171/2023.2.JNS222751

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。